Journal of Clinical & Experimental Hepatology
Volume 1, Issue 3 , Pages 185-189, December 2011

Occult Hepatitis C Virus Infection and Its Relevance in Clinical Practice

  • Tram NQ Pham
    • ,
  • Tomasz I Michalak

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Tomasz I Michalak, Molecular Virology and Hepatology Research Group, Faculty of Medicine, Health Sciences Center, Memorial University, St. John's, NL, Canada A1B 3V6

Molecular Virology and Hepatology Research Group, Division of Biomedical Sciences, Faculty of Medicine, Health Sciences Center, Memorial University, St. John's, NL, Canada A1B 3V6

Received 29 August 2011; accepted 30 August 2011.

Article Outline

Hepatitis C virus (HCV) can persist in the liver, lymphoid (immune) cells, and serum of individuals long after an apparently complete therapy-induced or a spontaneous resolution of hepatitis C. This essential asymptomatic infection, called secondary occult HCV infection (OCI), usually occurs in anti-HCV antibody reactive individuals with normal liver function tests. This infection has been identified when the nucleic acid amplification assays of enhanced sensitivity were applied for the detection of HCV genome and its replication. In addition to the secondary OCI, a form of low-level HCV-RNA-positive infection of unknown etiology coinciding with moderately elevated serum liver enzymes and progressing in the absence of anti-HCV detectable by standard clinical assays has been reported. Because of its undefined origin, it can be termed cryptogenic OCI. In this review, the general characteristics of OCI, the ways of its detection and associated controversies, and the potential clinical implications of its existence will be concisely outlined.

Keywords:  Clinical practice , hepatitis C , identification of OCI , occult HCV infection

Abbreviations:  CHC, chronic hepatitis C , HBV, hepatitis B virus , HCC, hepatocellular carcinoma , HCV, hepatitis C virus , IFN, interferon , IU, international unit , NAH, nucleic acid hybridization , OCI, occult HCV infection , PBMC, peripheral blood mononuclear cells , PCR, polymerase chain reaction , RBV, ribavirin , RNA, ribonucleic acid , SVR, sustained virological response

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Alberti A , Chemello L , Benvegnu L . Natural history of hepatitis C . J Hepatol . 1999;31:17–24
  2. Blackard JT , Kemmer N , Sherman KE . Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences . Hepatology . 2006;44:15–22
  3. Lerat H , Rumin S , Habersetzer F , et al.   In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype . Blood . 1998;91:3841–3849
  4. Pal S , Sullivan DG , Kim S , et al.   Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism . Gastroenterology . 2006;130:1107–1116
  5. Pham TN , King D , MacParland SA , et al.   Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection . Gastroenterology . 2008;134:812–822
  6. Zignego AL , Macchia D , Monti M , et al.   Infection of peripheral mononuclear blood cells by hepatitis C virus . J Hepatol . 1992;15:382–386
  7. MacParland SA , Pham TN , Gujar SA , Michalak TI . De novo infection and propagation of wild-type Hepatitis C virus in human T lymphocytes in vitro . J Gen Virol . 2006;87:3577–3586
  8. MacParland SA , Pham TN , Guy CS , Michalak TI . Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro . Hepatology . 2009;49:1431–1441
  9. Kondo Y , Sung VM , Machida K , Liu M , Lai MM . Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines . Virology . 2007;361:161–173
  10. Morsica G , Tambussi G , Sitia G , et al.   Replication of hepatitis C virus in B lymphocytes (CD19+) . Blood . 1999;94:1138–1139
  11. Castillo I , Rodriguez-Inigo E , Lopez-Alcorocho JM , Pardo M , Bartolome J , Carreno V . Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment . Clin Infect Dis . 2006;43:1277–1283
  12. Ciancio A , Smedile A , Giordanino C , et al.   Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured? . Am J Gastroenterol . 2006;101:1811–1816
  13. Pham TN , MacParland SA , Mulrooney PM , Cooksley H , Naoumov NV , Michalak TI . Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C . J Virol . 2004;78:5867–5874
  14. Radkowski M , Gallegos-Orozco JF , Jablonska J , et al.   Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C . Hepatology . 2005;41:106–114
  15. Castillo I , Pardo M , Bartolome J , et al.   Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown . J Infect Dis . 2004;189:7–14
  16. George SL , Bacon BR , Brunt EM , Mihindukulasuriya KL , Hoffmann J , Di Bisceglie AM . Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients . Hepatology . 2009;49:729–738
  17. Maylin S , Martinot-Peignoux M , Ripault MP , et al.   Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody . Liver Int . 2009;29:511–517
  18. Nicot F , Kamar N , Mariame B , Rostaing L , Pasquier C , Izopet J . No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients . Transpl Int . 2010;23:594–601
  19. Halfon P , Bourliere M , Ouzan D , et al.   Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay . J Clin Microbiol . 2008;46:2106–2108
  20. Bokharaei-Salim F , Keyvani H , Monavari SH , et al.   Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease . J Med Virol . 2011;83:989–995
  21. Zaghloul H , El Sherbiny W . Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells . Immunol Invest . 2010;39:284–291
  22. Pham TN , Coffin CS , Michalak TI . Occult hepatitis C virus infection: what does it mean? . Liver Int . 2010;30:502–511
  23. Pham TN , Coffin CS , Churchill ND , Urbanski SJ , Lee SS , Michalak TI . Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus . J Viral Hepat . 2011; (published online March 1, 2011).
  24. Pham TN , MacParland SA , Coffin CS , Lee SS , Bursey FR , Michalak TI . Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells . J Gen Virol . 2005;86:657–666
  25. Di Liberto G , Roque-Afonso AM , Kara R , et al.   Clinical and therapeutic implications of hepatitis C virus compartmentalization . Gastroenterology . 2006;131:76–84
  26. Ducoulombier D , Roque-Afonso AM , Di Liberto G , et al.   Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes . Hepatology . 2004;39:817–825
  27. Coppola N , Pisaturo M , Guastafierro S , et al.   Absence of occult HCV infection in patients under immunosuppressive therapy for oncohematological diseases . Hepatology . 2011;54:1487–1489
  28. Castillo I , Bartolome J , Quiroga JA , Barril G , Carreno V . Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection . Aliment Pharmacol Ther . 2009;30:477–486
  29. Germer JJ , Zein NN . Advances in the molecular diagnosis of hepatitis C and their clinical implications . Mayo Clin Proc . 2001;76:911–920
  30. Formann E , Steindl-Munda P , Hofer H , et al.   Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy . Aliment Pharmacol Ther . 2006;23:507–511
  31. Berasain C , Betes M , Panizo A , et al.   Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology . Gut . 2000;47:429–435
  32. Hoare M , Gelson WT , Rushbrook SM , et al.   Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection . Hepatology . 2008;48:1737–1745
  33. Charlton M , Seaberg E , Wiesner R , et al.   Predictors of patient and graft survival following liver transplantation for hepatitis C . Hepatology . 1998;28:823–830
  34. Lee WM , Poison JE , Carney DS , Sahin B , Gale M . Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir . J Infect Dis . 2005;192:1088–1092
  35. Lin A , Thadareddy A , Goldstein MJ , Lake-Bakaar G . Immune suppression leading to hepatitis C virus re-emergence after sustained virological response . J Med Virol . 2008;80:1720–1722
  36. Nudo CG , Cortes RA , Weppler D , Schiff ER , Tzakis AG , Regev A . Effect of pretransplant hepatitis C virus RNA status on posttransplant outcome . Transplant Proc . 2008;40:1449–1455
  37. Thomopoulos K , Giannakoulas NC , Tsamandas AC , et al.   Recurrence of HCV infection in a sustained responder after chemotherapy for non-Hodgkin's lymphoma: successful retreatment . Am J Med Sci . 2008;336:73–76
  38. Kobayashi S , Takeda T , Enomoto M , et al.   Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients . Liver Int . 2007;27:186–191
  39. Makiyama A , Itoh Y , Kasahara A , et al.   Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy . Cancer . 2004;101:1616–1622
  40. Veldt BJ , Saracco G , Boyer N , et al.   Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy . Gut . 2004;53:1504–1508
  41. Veldt BJ , Heathcote EJ , Wedemeyer H , et al.   Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis . Ann Intern Med . 2007;147:677–684
  42. Freeman AJ , Dore GJ , Law MG , et al.   Estimating progression to cirrhosis in chronic hepatitis C virus infection . Hepatology . 2001;34:809–816
  43. Casato M , Lilli D , Donato G , et al.   Occult hepatitis C virus infection in type II mixed cryoglobulinaemia . J Viral Hepat . 2003;10:455–459
  44. Pardo M , Castillo I , Arenas MD , et al.   Antiviral therapy in patients with occult HCV infection . Hepatology . 2005;42:658A
  45. Raimondo G , Allain JP , Brunetto MR , et al.   Statements from the Taormina expert meeting on occult hepatitis B virus infection . J Hepatol . 2008;49:652–657

PII: S0973-6883(11)60130-8

doi:10.1016/S0973-6883(11)60130-8

Journal of Clinical & Experimental Hepatology
Volume 1, Issue 3 , Pages 185-189, December 2011

Article Tools